Equity Issuances

Banzai International, Inc. issued 152,542 shares of common stock to Agile Lending, LLC for $180,000 aggregate value, $1.18 per share.

“(iii) on February 26, 2026, the Company issued 152,542 shares at $1.18 per share (aggregate value of $180,000.00)”

Banzai International, Inc. issued 130,208 shares of common stock to Agile Lending, LLC for $150,000 aggregate value, $1.152 per share.

“(ii) on February 9, 2026, the Company issued 130,208 shares at $1.152 per share (aggregate value of $150,000.00)”

Banzai International, Inc. issued 135,135 shares of common stock to Agile Lending, LLC for $150,000 aggregate value, $1.11 per share.

“(i) on January 27, 2026, the Company issued 135,135 shares at $1.11 per share (aggregate value of $150,000.00)”

Banzai International, Inc. issued 232,786 shares of common stock to Agile Capital Funding, LLC and Agile Lending, LLC for $284,000 aggregate value, $1.22 per share.

“On December 16, 2025, Banzai International, Inc., a Delaware corporation (the “Company”), entered into that certain Exchange Agreement (the “Exchange Agreement”), dated as of December 15, 2025, by and among Agile Capital Funding, LLC, a New York limited liability company (“Collateral Agent”) and Agile Lending, LLC, a Virginia limited liability company (“Agile"), on the one hand, and the Company, on the other hand. Pursuant to the Exchange Agreement, the Company exchanged 232,786 shares (the “Exchange Shares”) of its Class A common stock, par value $0.0001 per share (the “Common Stock”), valued at $1.22 per share, having an aggregate value of $284,000”

C2 Blockchain, Inc. issued 800,000 shares of common stock to an accredited investor for at a purchase price of $0.01 per share for aggregate gross proceeds of $8,000.

“On April 30, 2026, the Company issued 800,000 shares of the Company’s common stock to an accredited investor at a purchase price of $0.01 per share for aggregate gross proceeds of $8,000.”

C2 Blockchain, Inc. issued 3,000,000 shares of common stock to an accredited investor for at a purchase price of $0.01 per share for aggregate gross proceeds of $30,000.

“On April 28, 2026, the Company issued 3,000,000 shares of the Company’s common stock to an accredited investor at a purchase price of $0.01 per share for aggregate gross proceeds of $30,000.”

C2 Blockchain, Inc. issued convertible note to Labrys Fund II, L.P. for gross proceeds of $100,000.

“On April 23, 2026, the Company issued the Note described in Item 1.01 of this Current Report to Labrys Fund II, L.P. for gross proceeds of $100,000.”

Palomino Laboratories Inc. issued 374,761 warrants of warrant to Laidlaw & Company (UK) Ltd. for services as placement agent.

“The Placement Agent also received 374,761 warrants to purchase shares of Common Stock which are exercisable for five (5) years and have an exercise price equal to 120% of the lowest price per share of the shares of Common Stock issued or issuable to investors in the Offering (the “ Placement Agent Warrants ”).”

Palomino Laboratories Inc. issued 470,000 Shares of common stock to certain accredited investors for gross proceeds of $1,880,000.00.

“On April 30, 2026, the Company and certain accredited investors mutually agreed to effect, and effected, an additional closing, with respect to 470,000 Shares for gross proceeds of $1,880,000.00 (the “ Second Closing ”).”

Blue Owl Real Estate Net Lease Trust issued 10,872,543 of its common shares of common stock to multiple purchasers for gross proceeds of approximately $115.9 million.

“On May 1, 2026, Blue Owl Real Estate Net Lease Trust (the “ Company ,” “ ORENT ” “ we ” or “ us ”) sold an aggregate of 10,872,543 of its common shares for gross proceeds of approximately $115.9 million, based on net asset value per share as of March 31, 2026.”

RenX Enterprises Corp. issued 3,917,099 shares of Common Stock of warrant to certain institutional investors.

“and warrants (the “Initial Warrants”) to purchase an aggregate of 3,917,099 shares of Common Stock”

RenX Enterprises Corp. issued convertible note to certain institutional investors for $6,300,000 aggregate principal amount.

“the Company (i) issued and sold to the Purchasers, at the initial closing on May 4, 2026 (the “Initial Closing”), Notes in the aggregate principal amount of $6,300,000 (the “Initial Notes”)”

CH4 Natural Solutions Corp issued 200,000 units of unit to the Unit Holdings Sponsor for $10.00 per Private Placement Unit.

“On May 4, 2026, simultaneously with the closing of the IPO of the Company and pursuant to the Purchase Agreement, the Company completed the private sale of 200,000 units (the “ Private Placement Units ”) at a purchase price of $10.00 per Private Placement Unit to the Unit Holdings Sponsor, generating gross proceeds to the Company of $2,000,000.”

Stonepeak-Plus Infrastructure Fund LP issued 1,571,416 Class A-1a, 313,877 Class A-1b, 21,013 Class A-1c, 136,188 Class I-1, 1,524 Class S-1 of unit to third party investors for aggregate consideration of approximately $65,042,832.

“On April 1, 2026, Stonepeak-Plus Infrastructure Fund LP (the “Fund”) sold unregistered limited partnership units (the “Units”) to third party investors for aggregate consideration of approximately $65,042,832.”

ARC Group Acquisition I Corp. issued 200,000 units of unit to the Sponsor for purchase price of $10.00 per Private Placement Units, generating gross proceeds to the Company of $2,000,000.

“On May 1, 2026, simultaneously with the closing of the IPO, pursuant to the Private Units Purchase Agreement, the Company completed the private sale of an aggregate of 200,000 units (the “ Private Placement Units ”) to the Sponsor at a purchase price of $10.00 per Private Placement Units, generating gross proceeds to the Company of $2,000,000 (the “ Private Placement ”).”

Warburg Pincus Access Fund, L.P. issued 1,456,110 units (1,426,865 Class B1 + 29,245 Class B3) of unit to third-party investors for $37,263,800.

“On April 1, 2026, Warburg Pincus Access Fund, L.P. (the “Fund”) sold unregistered limited partnership units (the “Units”) for aggregate consideration of $37,263,800.”

Suncrete, Inc. issued 259,291 shares of Class A Common Stock of common stock to the seller in the acquisition of a ready-mix company for in connection with the acquisition of a ready-mix company.

“On April 29, 2026, Suncrete, Inc., a Delaware corporation (the “Company”), issued an aggregate of 259,291 shares of Class A Common Stock, par value $0.0001 per share, of the Company (“Class A Common Stock”) in connection with the acquisition of a ready-mix company.”

Forefront Tech Holdings Acquisition Corp issued 15,000 private placement units of unit to BTIG, LLC for $10.00 per Underwriter Private Placement Unit, generating gross proceeds of $150,000.

“Simultaneously with the closing of the IPO, pursuant to the Underwriter Private Placement Units Agreement, the Company completed the private sale of an aggregate of aggregate of 15,000 private placement units (the “ Underwriter Private Placement Units ”) to BTIG, LLC at a purchase price of $10.00 per Underwriter Private Placement Unit, generating gross proceeds of $150,000.”

Forefront Tech Holdings Acquisition Corp issued 355,000 private placement units of unit to Next Lion Sponsor Holdings LLC (the Sponsor) for $10.00 per Sponsor Private Placement Unit, generating gross proceeds to the Company of $3,550,000.

“Simultaneously with the closing of the IPO, pursuant to the Sponsor Private Placement Unit Agreement, the Company completed the private sale of an aggregate of aggregate of 355,000 private placement units (the “ Sponsor Private Placement Units ”) to the Sponsor at a purchase price of $10.00 per Sponsor Private Placement Unit, generating gross proceeds to the Company of $3,550,000.”

Mountain Crest Acquisition 6 Corp. issued 65,000 Private Placement Units of unit to D. Boral Capital LLC for $10.00 per unit; satisfaction of underwriting fee.

“On April 29, 2026, the Company elected to satisfy a portion of the underwriting fee owed to D. Boral by issuing 65,000 Private Placement Units at a price of $10.00 per unit.”

Mountain Crest Acquisition 6 Corp. issued 90,000 private units of unit to Mountain Crest Holdings 6 LLC for $10.00 per Private Unit, total proceeds $900,000.

“Simultaneously with the closing of the IPO, the Company consummated a private placement (the "Private Placement") with Mountain Crest Holdings 6 LLC, the Company's sponsor (the "Sponsor"), and D. Boral Capital LLC ("D. Boral"), pursuant to which the Sponsor purchased an aggregate of 90,000 private units (the "Private Units") at a price of $10.00 per Private Unit, generating total proceeds of $900,000.”

Oncotelic Therapeutics, Inc. issued a number of shares of Common Stock equal to ten percent (10%) of the fully diluted outstanding shares of common stock to Autotelic, Inc..

“In connection with the Asset Transfer Agreement described in Item 1.01 above, the Company has agreed to issue to Autotelic, Inc. a number of shares of Common Stock equal to ten percent (10%) of the fully diluted outstanding shares of Oncotelic Therapeutics, Inc. with the issuance conditioned on an uplisting of its capital stock to NYSE/NASDAQ.”

Track Group, Inc. issued 750,000 warrants to purchase common stock of warrant to certain accredited investors for Issued in connection with private placement; no separate consideration; aggregate gross proceeds of $10,315,000 for the offering.

“Shares ”) at a price per PIPE Share of $0.35, and (ii) 750,000 warrants to purchase shares of Common Stock (the “ PIPE Warrants ”). for aggregate gross proceeds of approximately $10,315,000. The PIPE Shares and PIPE Warrants sold in the Offering are sometimes hereafter referred to as, the “ Securities. ” The Company intends to use the proceeds from the Offering for”

Track Group, Inc. issued 29,471,429 shares of common stock of common stock to certain accredited investors for $0.35 per share for aggregate gross proceeds of approximately $10,315,000.

“29,471,429 shares of the Company’s common stock, par value $0.0001 per share (“ Common Stock ”) (the “ PIPE Shares ”) at a price per PIPE Share of $0.35, and (ii) 750,000 warrants to purchase shares of Common Stock (the “ PIPE Warrants ”).”

Ameresco, Inc. issued unit to an affiliate of HA Sustainable Infrastructure Capital, Inc. (HASI) for $400 million.

“in exchange for Class A units of the Joint Venture (the “Class A Units”), representing a 70% equity interest of the Joint Venture; and 2. at the Closing, JV Investor will invest $400 million in the Business, in exchange for Class B units of the Joint Venture (the “Class B Units”), representing a 30% equity interest of the Joint Venture. Of the $400 million investment”

EKSO BIONICS HOLDINGS, INC. issued 1,311,407 shares of common stock to Applied Parent for $12.01 per share.

“APLD Parent PIPE Investment In connection with, and as a condition to Closing, on May 1, 2026, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with Applied Parent (the “APLD Parent PIPE Investment”), pursuant to which the Company agreed to sell and issue to Applied Parent 1,311,407 shares of Common Stock (the “Private Placement Shares”). The Private Placement Shares will be sold in the APLD Parent PIPE Investment at an offering price of $12.01 per share, the closing price of the Common Stock on April 30, 2026, the date immediately preceding the date of execution of the Securities Purchase Agreement, for gross proceeds of approximately $15.75 million.”

CNS Pharmaceuticals, Inc. issued 9,143,479 shares of warrant to institutional investors for $2.299 per Pre-Funded Warrant.

“pre-funded warrants to purchase 9,143,479 shares of the Common Stock (the “Pre-Funded Warrants”) at a purchase price of $2.299 per Pre-Funded Warrant”

CNS Pharmaceuticals, Inc. issued 650,000 shares of common stock to institutional investors for $2.30 per share.

“the Investors purchased in a private placement: (i) 650,000 shares of the Company’s common stock, $0.001 par value per share (“Common Stock”) at a purchase price of $2.30 per share”

NKGen Biotech, Inc. issued warrant for exercise price of $0.08 per share.

“the Additional Warrant, which is exercisable for shares of Common Stock at an exercise price of $0.08 per share”

NKGen Biotech, Inc. issued convertible note for conversion price of $0.08 per share.

“the Additional Note, which is convertible into shares of Common Stock at a conversion price of $0.08 per share”

NKGen Biotech, Inc. issued common stock.

“on April 28, 2026, the Company agreed to issue to the Lender the following securities”

Rivian Automotive, Inc. / DE issued 19,553,911 shares of common stock to SMB Holding Corporation for $300 million.

“upon receipt of $300 million from SMB, the Company issued 19,553,911 shares of its Class A common stock to SMB at a purchase price per share of $15.3422.”

Partners Group Lending Fund, LLC issued Class I Units 28,640,070 and Class M Units 92,464 of unit to accredited investors for $42,857,000 for Class I Units, $138,363 for Class M Units.

“investors who are “accredited investors” within the meaning of Regulation D under the Securities Act. Unit Class Number of Units 1 Total Consideration Class I Units 28,640,070 $ 42,857,000 Class M Units 92,464 $ 138,363 1 Figures rounded to the nearest whole Unit”

Tamboran Resources Corp issued 99,375,000 CHESS Depositary Interests (CDIs) underpinned by 496,875 shares of common stock of common stock to existing shareholders resident in Australia, Bermuda, Canada, Cayman Islands, Germany, Hong Kong, New Zealand, Norway, Singapore, Switzerland, United Arab Emirates, or the United Kingdom for aggregate proceeds to the Company of A$24.8 million at an issue price of A$0.25 per CDI.

“On May 1, 2026, Tamboran Resources Corporation (the “Company”) settled a retail entitlement offer (“Retail Entitlement Offer”) and issued an aggregate of 99,375,000 CHESS Depositary Interests (“CDIs”) underpinned by 496,875 shares of common stock (each CDI represents 1/200th of a share of common stock), for aggregate proceeds to the Company of A$24.8 million at an issue price of A$0.25 per CDI.”

XCF Global, Inc. issued 4,000,000 shares of common stock to Twain GL XXVIII, LLC.

“In consideration of Twain’s forbearance, XCF agreed to issue 4,000,000 shares of XCF Common Stock (the “ 2026 Landlord Shares ”) to Twain and agreed to use its reasonable best efforts to file a registration statement on appropriate form with the SEC to register the 2026 Landlord Shares for resale.”

SL Investment Fund II LLC issued approximately 1,492,462 shares of common stock to accredited investors for aggregate offering price of $29.7 million.

“On April 23, 2026, the Company delivered a capital drawdown notice to its unitholders relating to the sale of approximately 1,492,462 shares of the Company’s common units, par value $0.001 per share (the “Common Units”) for an aggregate offering price of $29.7 million. The sale closed on April 30, 2026.”

PIMCO Asset-Based Lending Co LLC issued securities to third party investors for cash.

“On April 1, 2026, PIMCO Asset-Based Lending Company LLC (the “Company”) (including PIMCO Asset-Based Lending Company LLC - Series I (“Series I”) and PIMCO Asset-Based Lending Company LLC - Series II (“Series II” and, together with Series I, the “Series”)) issued and sold the following unregistered limited liability company interests of the Company (the “Shares”) for each of Series I and Series II (with the final number of Shares of each class (each, a “Class”) being determined on April 28, 2026) to third party investors for cash:”

West Enclave Merger Corp. issued 425,000 units of unit to Sponsor and EBC (and its affiliates or permitted assignees) for $10.00 per Private Placement Unit.

“On May 1, 2026, simultaneously with the consummation of the Offering, the Company consummated the private placement of an aggregate of 425,000 units (the “Private Placement Units”) to the Sponsor and EBC (and its affiliates or permitted assignees) at a price of $10.00 per Private Placement Unit, generating gross proceeds of $4,250,000 (the “Private Placement”).”

General Catalyst Global Resilience Merger Corp. issued 905,000 Private Placement GRAIL Securities of unit to GCGR Sponsor LLC for $10.00 per Private Placement GRAIL Security.

“the Company consummated the private placement of 905,000 Private Placement GRAIL Securities at a price of $10.00 per Private Placement GRAIL Security, generating total proceeds of $9,050,000.”

Collective Acquisition Corp. II issued 165,000 of common stock to Clear Street LLC (as representative of the Underwriters) for part of the Offering; no additional consideration mentioned.

“The Company also issued in a private placement to the Underwriters 165,000 Class A Ordinary Shares upon the consummation of the Offering (the “ Representative Shares ”).”

Collective Acquisition Corp. II issued 5,837,500 of warrant to Collective Acquisition Sponsor II LLC for $0.80 per Private Placement Warrant, generating gross proceeds of $4,670,000.

“Simultaneously with the closing of the Offering, pursuant to the Private Placement Warrants Purchase Agreement, the Company completed the private sale of an aggregate of 5,837,500 warrants (the “ Private Placement Warrants ”) to the Sponsor at a purchase price of $0.80 per Private Placement Warrant, generating gross proceeds to the Company of $4,670,000.”

Dror Ortho-Design, Inc. issued convertible note to purchasers signatory to the Securities Purchase Agreement for an aggregate principal amount of $275,000.

“the Company agreed to sell to the Purchasers in a private placement (the “Private Placement”), Debentures (the “Debentures”) in an aggregate principal amount of $275,000”

HNO International, Inc. issued 500,000 shares of Common Stock as initial commitment shares of common stock to Lambda Ventures LLC.

“As consideration for the Investor’s commitment to enter into the Purchase Agreement, the Company agreed to issue to the Investor 500,000 shares of Common Stock as initial commitment shares (the “Initial Commitment Shares”), which are earned in full upon execution of the Purchase Agreement.”

Netcapital Inc. issued convertible note to Vanquish Funding Group Inc. for aggregate purchase price of $125,000.

“On April 26, 2026, Netcapital Inc. (the “Company”) entered into two Securities Purchase Agreements with Vanquish Funding Group Inc., a Virginia corporation, pursuant to which the Company issued two promissory notes in the aggregate principal amount of $144,550 for an aggregate purchase price of $125,000, reflecting an aggregate original issue discount of $19,550.”

iQSTEL Inc issued Commitment Shares valued at $1,000,000 of common stock to M2B Funding Corp. for commitment to purchase up to $50,000,000 of Common Stock.

“M2B Funding Corp. (the “Investor”). Pursuant to the Purchase Agreement, the Company may, from time to time during the Commitment Period, require the Investor to purchase up to $50,000,000 of the Company’s common stock, par value $0.0001 per share (“Common Stock”), at a per-share price equal to 94% of the lowest daily volume-weighted average price during the six”

Lunai Bioworks Inc. issued preferred stock for $20,000,000.

“of the Company, the holders of the Series B Preferred Stock are entitled to a senior liquidation preference equal to the aggregate Stated Value of the Series B Preferred Stock ($20,000,000), and to the extent that, upon receipt of the Stockholder Approval, the Series B Preferred Stock will become convertible into shares of common stock at a fixed Conversion Price”

authID Inc. issued 15% of the principal amount invested by each investor divided by $1.00 of common stock to certain accredited investors.

“the Company issued to the Investors "Fee Shares" equal to 15% of the principal amount invested by each investor divided by $1.00”

authID Inc. issued warrant to certain accredited investors.

“The issuance of the Warrants and Fee Shares constitutes an unregistered sale of equity securities.”

Clearway Energy, Inc. issued common stock.

“On April 29, 2026, at the Annual Meeting of Stockholders (the “Annual Meeting”) of Clearway Energy, Inc. (the “Company”), the stockholders of the Company approved, among other things, an amendment and restatement of the Certificate of Incorporation of the Company (the “Amended Charter”). Following receipt of stockholder approval at the Annual Meeting, on April 29, 2026, the Amended Charter was filed with the Secretary of State of the State of Delaware (the “Delaware Secretary of State”) and became effective.”

American Strategic Investment Co. issued 232,098 shares of common stock to New York City Advisors, LLC (the "Advisor") for $1,910,169.12.

“the Company has accrued and owes to the Advisor cash compensation in the aggregate amount of $1,910,169.12, which the Advisor has elected to receive in the form of shares of the Company’s Class A common stock”